On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Baekseok Culture University

InstitutionResearch output, impact & collaborations

Baekseok Culture University is a institution indexed in ScholarIQ from OpenAlex.

What is known about Baekseok Culture University?

ScholarIQrecord summary

Baekseok Culture University is a research organisation in Cheonan, South Korea. OpenAlex records 285 works and 2,678 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Baekseok Culture University have?

ScholarIQindexed works

Baekseok Culture University has 285 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Baekseok Culture University have?

ScholarIQcitation count

Baekseok Culture University has 2,678 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Baekseok Culture University?

ScholarIQresearcher count

Baekseok Culture University has 1 researchers in the ScholarIQ index.

What is the average h-index at Baekseok Culture University?

ScholarIQavg h-index

Baekseok Culture University has an average h-index of 70 in OpenAlex.

What is the ROR of Baekseok Culture University?

ScholarIQror

The ROR for Baekseok Culture University is on the source record.

What is the OpenAlex record for Baekseok Culture University?

ScholarIQopenalex

The OpenAlex for Baekseok Culture University is on the source record.

Who are the most-cited researchers behind Baekseok Culture University?

ScholarIQtop researchers by citations
1
Ji‐Youn Han · Lung Cancer Treatments and Mutations
492 works25,653 citations

What are the most-cited papers on Baekseok Culture University?

ScholarIQmost cited works
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
The Lancet. 20156,558 Citations
Capmatinib in <i>MET</i> Exon 14–Mutated or <i>MET</i> -Amplified Non–Small-Cell Lung Cancer
Jürgen Wolf, Takashi Seto, Ji‐Youn Han, Noemı́ Reguart, Edward B. Garon, Harry J.M. Groen, Daniel S.W. Tan, Toyoaki Hida, Maja J.A. de Jonge, Sergey Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Maximilian J. Hochmair, Enriqueta Felip, Makoto Nishio, Michael Thomas, Kadoaki Ohashi, Ryo Toyozawa, Tobias R. Overbeck, Filippo de Marinis, Tae Min Kim, Eckart Laack, Anna Robeva, Sylvie Le Mouhaër, Maeve Waldron-Lynch, B. Sankaran, O. Alejandro Balbin, Xiaoming Cui, Monica Giovannini, Mikhail Akimov, Rebecca S. Heist
New England Journal of Medicine. 20201,009 CitationsOPEN ACCESS
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer
D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Jong Seok Lee, Maximilian J. Hochmair, Jacky Yu-Chung Li, Gee‐Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Rosario García Campelo, Dong‐Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Neeraj Gupta, J. Haney, David Kerstein, Sanjay Popat
New England Journal of Medicine. 2018987 CitationsOPEN ACCESS
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
Paul K. Paik, Enriqueta Felip, Rémi Veillon, Hiroshi Sakai, Alexis B. Cortot, Marina Chiara Garassino, Julien Mazières, Santiago Viteri, Hélène Senellart, Jan P. van Meerbeeck, Jo Raskin, Niels Reinmuth, PierFranco Conte, Dariusz M. Kowalski, Byoung Chul Cho, Jyoti D. Patel, Leora Horn, Frank Griesinger, Ji‐Youn Han, Young‐Chul Kim, Gee‐Chen Chang, Chen‐Liang Tsai, James Chih‐Hsin Yang, Yuh-Min Chen, Egbert F. Smit, Anthonie J. van der Wekken, Terufumi Kato, Dilafruz Juraeva, Christopher Stroh, Rolf Bruns, Josef Straub, Andreas Johne, J. Scheele, John V. Heymach, Xiuning Le
New England Journal of Medicine. 2020872 CitationsOPEN ACCESS
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
Ji‐Youn Han, Keunchil Park, Sang‐We Kim, Ki Hyeong Lee, Hyae Young Kim, Heung Tae Kim, Myung‐Ju Ahn, Tak Yun, Jin Seok Ahn, Cheolwon Suh, Jung‐Shin Lee, Sung Jin Yoon, Jong Hee Han, Jae‐Won Lee, Sook Jung Jo, Jin Soo Lee
Journal of Clinical Oncology. 2012735 Citations

How much of the research on Baekseok Culture University is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
33%
Bronze
25%
Closed
25%
470M+ articles · free account